Erythromer: nanoscale BIO-synthetic red cell substitute
Ended Project Grant Awarded Last action
- Award ID
- R42HL135965
- Recipient
-
Kalocyte Inc. UEI MJMKM31FM667
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,019,830
Award facts
- Assistance listing
- 93.837 Cardiovascular Diseases Research
- Completion date
- Originally
- Place of performance
- Missouri, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $788,480 | |
| Amendment | $0 | |
| Amendment | $833,728 | |
| Original award | $397,622 |
Show all 12
Quick answers
Who received award R42HL135965?
R42HL135965 was awarded to Kalocyte Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on May 11, 2017.
How much is award R42HL135965 worth?
$2,019,830 has been obligated on R42HL135965.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award